BINGLEY MEDICAL PRACTICE — All Prescriptions & Medications — Page 11
Practice Code: B83014 | BINGLEY, BD16 4RP
Showing results 501-550 of 671
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Carmellose sodium | 24 | 2,850 | £339 | -63.0% ▼ |
| Fluocinolone acetonide | 24 | 1,850 | £221 | +120.4% ▲ |
| 24 | 536 | £625 | -5.5% ▼ | |
| 24 | 44 | £278 | -32.9% ▼ | |
| 24 | 660 | £313 | -26.9% ▼ | |
| Eprosartan | 23 | 1,288 | £626 | +13.9% ▲ |
| Galantamine | 23 | 644 | £1.3K | -39.2% ▼ |
| 23 | 23 | £122 | -55.2% ▼ | |
| 23 | 1,050 | £677 | -11.7% ▼ | |
| 23 | 710 | £1.9K | +40.9% ▲ | |
| Bempedoic acid | 22 | 784 | £1.5K | -32.9% ▼ |
| Fesoterodine fumarate | 22 | 784 | £67 | -44.2% ▼ |
| 22 | 83 | £470 | -20.9% ▼ | |
| Labetalol hydrochloride | 21 | 1,288 | £106 | -7.5% ▼ |
| Aclidinium bromide/formoterol | 21 | 26 | £803 | -40.3% ▼ |
| Midazolam hydrochloride | 21 | 84 | £1.9K | +45.7% ▲ |
| Mercaptopurine | 21 | 1,027 | £473 | +35.6% ▲ |
| 21 | 1,050 | £1.5K | +114.7% ▲ | |
| Indacaterol maleate | 20 | 600 | £612 | +130.5% ▲ |
| Safinamide | 20 | 750 | £1.6K | -0.7% vs avg |
| RtS 1.5 kcal/g dessert style (milk based) (0913021) | 20 | 40.0K | £1.0K | +145.2% ▲ |
| Fusidic acid | 20 | 100 | £390 | +93.6% ▲ |
| Ketoconazole | 20 | 780 | £105 | +101.0% ▲ |
| 20 | 96 | £97 | +92.5% ▲ | |
| 20 | 2,220 | £457 | -31.9% ▼ | |
| Formoterol/glycopyrronium/budesonide | 19 | 19 | £803 | -68.4% ▼ |
| Cocois | 19 | 1,700 | £293 | +38.4% ▲ |
| 19 | 19 | £195 | +90.0% ▲ | |
| 19 | 1,410 | £325 | +78.6% ▲ | |
| Metoprolol tartrate | 18 | 1,634 | £160 | -64.5% ▼ |
| Fenofibrate | 18 | 952 | £106 | -81.4% ▼ |
| Citalopram hydrochloride | 18 | 330 | £232 | +12.1% ▲ |
| Vortioxetine | 18 | 1,007 | £948 | -74.1% ▼ |
| Eletriptan | 18 | 144 | £513 | +82.3% ▲ |
| Lacosamide | 18 | 2,064 | £262 | -66.5% ▼ |
| Phenobarbital | 18 | 504 | £50 | -41.5% ▼ |
| Exenatide | 18 | 33 | £1.4K | +2.7% ▲ |
| Capsaicin | 18 | 990 | £524 | +128.0% ▲ |
| Azelastine hydrochloride | 18 | 440 | £200 | +60.6% ▲ |
| 18 | 855 | £201 | -39.7% ▼ | |
| 18 | 232 | £896 | +229.8% ▲ | |
| 18 | 310 | £108 | -37.8% ▼ | |
| 18 | 18 | £330 | +393.9% ▲ | |
| Mebeverine hydrochloride compound preparations | 17 | 734 | £639 | +50.4% ▲ |
| Phosphates (Rectal) | 17 | 137 | £1.3K | +39.1% ▲ |
| Methyldopa | 17 | 1,848 | £1.5K | -0.2% vs avg |
| Amantadine hydrochloride | 17 | 3,936 | £3.4K | -39.0% ▼ |
| Rifaximin | 17 | 924 | £4.3K | -36.7% ▼ |
| Powder amino acid formula (0913131) | 17 | 115.6K | £11.1K | +59.4% ▲ |
| Tube feed 1 kcal/ml peptide based (0914041) | 17 | 555.5K | £18.0K | +91.3% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.